These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22301853)

  • 1. Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein.
    Holthoewer D; Endres K; Schuck F; Hiemke C; Schmitt U; Fahrenholz F
    Neurodegener Dis; 2012; 10(1-4):224-8. PubMed ID: 22301853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
    Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
    PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
    Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
    FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoids as a perspective in treatment of Alzheimer's disease.
    Fahrenholz F; Tippmann F; Endres K
    Neurodegener Dis; 2010; 7(1-3):190-2. PubMed ID: 20224284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extract of Caragana sinica as a potential therapeutic option for increasing alpha-secretase gene expression.
    Schuck F; Schmitt U; Reinhardt S; Freese C; Lee IS; Thines E; Efferth T; Endres K
    Phytomedicine; 2015 Oct; 22(11):1027-36. PubMed ID: 26407945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
    Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
    J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
    Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
    J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice.
    Schmitt U; Hiemke C; Fahrenholz F; Schroeder A
    Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
    Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
    Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
    Webster NJ; Green KN; Settle VJ; Peers C; Vaughan PF
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):161-9. PubMed ID: 15519686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Schroeder A; Fahrenholz F; Schmitt U
    J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
    Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
    FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex.
    Ohtake N; Saito M; Eto M; Seki K
    Regul Pept; 2014 May; 190-191():1-11. PubMed ID: 24769307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
    Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
    J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
    Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.
    Reinhardt S; Stoye N; Luderer M; Kiefer F; Schmitt U; Lieb K; Endres K
    Sci Rep; 2018 Jan; 8(1):1329. PubMed ID: 29358714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice.
    Kitaoka K; Shimizu N; Ono K; Chikahisa S; Nakagomi M; Shudo K; Ishimura K; Séi H; Yoshizaki K
    Neuropharmacology; 2013 Sep; 72():58-65. PubMed ID: 23624141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of α-secretase ADAM10 expression and activity.
    Endres K; Fahrenholz F
    Exp Brain Res; 2012 Apr; 217(3-4):343-52. PubMed ID: 21969210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.